These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7382187)

  • 101. The value of angiography of the small branches of the abdominal aorta.
    Kahn PC; Frates RE
    Am J Roentgenol Radium Ther Nucl Med; 1968 Feb; 102(2):407-17. PubMed ID: 5635693
    [No Abstract]   [Full Text] [Related]  

  • 102. Testicular I-131 6beta-iodomethyl-19-norcholesterol uptake in a patient with adrenogenital syndrome.
    Assi ZI; Bohnen NI; Schteingart DE; Gross MD; Shapiro B
    Clin Nucl Med; 1999 Jun; 24(6):464. PubMed ID: 10361955
    [No Abstract]   [Full Text] [Related]  

  • 103. Tissue distribution studies in rats with two 131I-labeled adrenal scanning agents. Comparison between 131I-6-iodomethyl-19-norsitost-5(10)-en-3 beta-ol (NST-6-131I) and 19-iodositost-5-en-3 beta-ol (ST-19-131I).
    Ito T; Yamauchi S; Maeda M; Komatsu H; Kojima M
    Int J Nucl Med Biol; 1979; 6(3):163-6. PubMed ID: 521221
    [No Abstract]   [Full Text] [Related]  

  • 104. [A quantitative evaluation of adrenal scintigraphy (author's transl)].
    Onishi R; Nishiyama S; Matsuo M; Ito K; Ushio K; Inoue Y; Takahashi R
    Radioisotopes; 1979 Apr; 28(4):231-5. PubMed ID: 482657
    [No Abstract]   [Full Text] [Related]  

  • 105. [Comparative study of adrenal gland scanning agents, 6beta-iodomethyl-19-nor-cholest-5(10)-en-3beta-o1-131I (NCL-6-131I) and 131I-19-cholesterol (CL-19-131I)].
    Fukuchi S; Nakajima K; Miura T; Haruyama K; Kida T
    Kaku Igaku; 1976 Dec; 13(6):775-9. PubMed ID: 1035359
    [No Abstract]   [Full Text] [Related]  

  • 106. In-depth description of adrenal imaging agents.
    Couch MW; Scott KN; Brookeman VA; Mareci TH
    Semin Nucl Med; 1978 Oct; 8(4):365. PubMed ID: 754290
    [No Abstract]   [Full Text] [Related]  

  • 107. [Whole body retention and tissue distribution studies of 75Se-selenonorcholesterol and evaluation of radiation dose--comparison with NCL-6-131I].
    Mori H; Futatsuya R; Seto H; Koizumi K; Ando A; Hisada K
    Radioisotopes; 1979 Feb; 28(2):89-91. PubMed ID: 451277
    [No Abstract]   [Full Text] [Related]  

  • 108. [Potential adrenal gland imaging agents. II: Radioiodination of p-hydroxyphenyl derivatives of digitoxigenin, dihydrodigitoxigenin and scillarenin].
    Röder E; Lütz J
    Arch Pharm (Weinheim); 1985 Oct; 318(10):882-8. PubMed ID: 4084020
    [No Abstract]   [Full Text] [Related]  

  • 109. Commentary on Apparent Bilateral Adrenal Suppression.
    Sacks BA
    J Vasc Interv Radiol; 2021 May; 32(5):666-667. PubMed ID: 33933249
    [No Abstract]   [Full Text] [Related]  

  • 110. Adrenal scanning with dichloro-diphenyl-dichloroethane-131I (DDD-131I)--a clinical report on 100 subjects.
    Skromne-Kadlubik C; Alvarez-Cervera J; Cortes-Marmolejo F
    Int J Nucl Med Biol; 1975 Mar; 2(2):83-6. PubMed ID: 1176268
    [No Abstract]   [Full Text] [Related]  

  • 111. [Potential radiopharmaceutical for adrenal gland scintigraphy. 1. Radioiodination of tyramine derivatives of some derivatives of digitoxigenin and scillarenin].
    Röder E; Lütz J
    Arch Pharm (Weinheim); 1985 Sep; 318(9):837-42. PubMed ID: 4084030
    [No Abstract]   [Full Text] [Related]  

  • 112. Potential organ- or tumor-imaging agents. 13. 19-Radioiodinated sterols.
    Counsell RE; Kulkarni PG; Afiatpour P; Ranade VV
    J Med Chem; 1973 Aug; 16(8):945-7. PubMed ID: 4745840
    [No Abstract]   [Full Text] [Related]  

  • 113. [Affinity of adrenal glands for gamma emittor 103Ru as acetylruthenocen].
    Wenzel M; Subramanian N; Nipper E
    Naturwissenschaften; 1976 Jul; 63(7):341. PubMed ID: 967272
    [No Abstract]   [Full Text] [Related]  

  • 114. Tumor localizing agents. IV. Radioiodinated analogs of 1,1-dichloro-2,2-di(chlorophenyl)ethane.
    Counsell RE; Ranade VV; Lala LK; Hong BH
    J Med Chem; 1968 Mar; 11(2):380-2. PubMed ID: 5663635
    [No Abstract]   [Full Text] [Related]  

  • 115. [Potential radiopharmaceuticals for adrenal gland scintigraphy. 3. Animal experimental studies with 131Iodine labeled tyraminyl- and p-hydroxyphenyl-aglycones].
    Röder E; Lütz J; Biersack HJ; Winkler C
    Arch Pharm (Weinheim); 1985 Dec; 318(12):1115-25. PubMed ID: 4096631
    [No Abstract]   [Full Text] [Related]  

  • 116. An adverse reaction to [6-131I]iodomethylnorcholestrol.
    Maltby PJ; Smith ML
    Nucl Med Commun; 2002 May; 23(5):505-6. PubMed ID: 12026881
    [No Abstract]   [Full Text] [Related]  

  • 117. Computing adrenal uptakes with compact, fixed-size regions.
    Koral KF; Abukhadra H; Tuscan M; Beierwaltes WH
    Comput Programs Biomed; 1982 Aug; 15(1):73-7. PubMed ID: 7128125
    [TBL] [Abstract][Full Text] [Related]  

  • 118. [Measurement of percent uptake in the adrenal glands with 131I-adosterol (author's transl)].
    Fujita T; Fukunaga M; Mukai T; Yamamoto I; TorizukaD okoh S; Ishii Y; Morita R; Kawamura K; Kawamura J
    Kaku Igaku; 1980 Mar; 17(2):219-27. PubMed ID: 7382187
    [No Abstract]   [Full Text] [Related]  

  • 119. [Adrenal scintigraphy using 131I-adosterol--as to the usefulness of dexamethasone suppression scintigraphy (author's transl)].
    Fukunaga M; Dokoh S; Yamamoto I; Morita R; Torizuka K; Fujita T; Kono T; Tanimura H; Shinpo S
    Radioisotopes; 1977 Dec; 26(12):864-8. PubMed ID: 605223
    [No Abstract]   [Full Text] [Related]  

  • 120. Absorbed dose to the human adrenals from lodomethylnorcholesterol (I-131) "NP-59": concise communication.
    Carey JE; Thrall JH; Freitas JE; Beierwaltes WH
    J Nucl Med; 1979 Jan; 20(1):60-2. PubMed ID: 430180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.